Padagis Us Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PADAGIS US
PADAGIS US has ninety-two approved drugs.
There is one US patent protecting PADAGIS US drugs.
Summary for Padagis Us
| US Patents: | 1 |
| Tradenames: | 68 |
| Ingredients: | 63 |
| NDAs: | 92 |
| Patent Litigation for Padagis Us: | See patent lawsuits for Padagis Us |
| PTAB Cases with Padagis Us as petitioner: | See PTAB cases with Padagis Us as petitioner |
Drugs and US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 205993-001 | Nov 5, 2015 | AB2 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | FLUOCINONIDE | fluocinonide | GEL;TOPICAL | 209030-001 | Jun 19, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | DIHYDROERGOTAMINE MESYLATE | dihydroergotamine mesylate | INJECTABLE;INJECTION | 040475-001 | Apr 28, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | AZELASTINE HYDROCHLORIDE | azelastine hydrochloride | SPRAY, METERED;NASAL | 202609-001 | Mar 17, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Padagis Us | DESONIDE | desonide | OINTMENT;TOPICAL | 017426-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | HYDROMORPHONE HYDROCHLORIDE | hydromorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204278-004 | Sep 20, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | MORPHINE SULFATE | morphine sulfate | SOLUTION;ORAL | 201574-001 | Aug 6, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Padagis Us
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,299,900 | ⤷ Start Trial |
| Padagis Us | CLINDESSE | clindamycin phosphate | CREAM;VAGINAL | 050793-001 | Nov 30, 2004 | 5,266,329 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 4,078,071 | ⤷ Start Trial |
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,818,226 | ⤷ Start Trial |
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,978,945 | ⤷ Start Trial |
| Padagis Us | EVAMIST | estradiol | SPRAY;TRANSDERMAL | 022014-001 | Jul 27, 2007 | 6,923,983 | ⤷ Start Trial |
| Padagis Us | BUTOCONAZOLE NITRATE | butoconazole nitrate | CREAM;VAGINAL | 019881-001 | Feb 7, 1997 | 5,993,856 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PADAGIS US drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Vaginal Cream | 2% | ➤ Subscribe | 2015-02-05 |
| ➤ Subscribe | Enteric Coated Capsules | 3 mg | ➤ Subscribe | 2008-02-01 |
International Patents for Padagis Us Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 200870154 | ⤷ Start Trial |
| Japan | 2007505927 | ⤷ Start Trial |
| Brazil | PI0620905 | ⤷ Start Trial |
| China | 101374502 | ⤷ Start Trial |
| Argentina | 058897 | ⤷ Start Trial |
| Israel | 192565 | ⤷ Start Trial |
| European Patent Office | 1667619 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Padagis Us Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2515855 | CR 2018 00002 | Denmark | ⤷ Start Trial | PRODUCT NAME: A COMBINATION OF GLYCOPYRRONIUM BROMIDE, FORMOTEROL OR A SALT THEREOF, INCLUDING FORMOTEROL FUMARATE DIHYDRATE, AND BECLOMETASONE DIPROPIONATE; REG. NO/DATE: EU/1/17/1208 20170719 |
| 1453521 | 15C0050 | France | ⤷ Start Trial | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
| 3043773 | 2022C/520 | Belgium | ⤷ Start Trial | PRODUCT NAME: MOMETASONE OF EEN ZOUT HIERVAN EN OLOPATADINE OF EEN ZOUT HIERVAN; AUTHORISATION NUMBER AND DATE: BE595626 20220203 |
| 0617614 | C300043 | Netherlands | ⤷ Start Trial | PRODUCT NAME: ALITRETINOIN; NAT. REGISTRATION NO/DATE: EU/1/00/149/001 20001011; FIRST REGISTRATION: EU/1/00/149/001 20001011 |
| 2957286 | CR 2018 00043 | Denmark | ⤷ Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179/001-009 20170721 |
| 0720599 | CR 2014 00050 | Denmark | ⤷ Start Trial | PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910 |
| 1267866 | 2013/014 | Ireland | ⤷ Start Trial | PRODUCT NAME: GLYCOPYRRONIUM OR A SALT THEREOF; REGISTRATION NO/DATE: EU/1/12/788/001-006 20120928 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
